| (dMMR) | mismatch repair deficient |
| (FDA) | Food and Drug Administration |
| (HCL) | hairy cell leukemia |
| (IL-2) | interleukin-2 |
| (EU) | European Union |
| (US) | United States |
| (PD-1) | programmed cell death protein-1 |
| (CTLA-4) | cytotoxic T -lymphocyte-associated protein-4 |
| (ICPIs) | immune checkpoint inhibitors |
| (PD-L1 and PD-L2) | programmed cell death ligands 1 and 2 |
| (CHO) | Chinese hamster ovary |
| (ADCC) | antibody-dependent cellular cytotoxicity |
| (CDC) | complement-dependent cytotoxicity |
| (ADA) | anti-drug antibodies |
| (NSCLC) | nonsmall cell lung cancer |
| (PBMCs) | human peripheral blood mononuclear cells |
| (PopPk) | population PK |
| (CL) | clearance |
| (ER) | exposure-response |
| (AEs) | adverse events |
| (TMBST) | tumor mutational burden status |
| (ORR) | overall response rate |
| (APCs) | antigen-presenting cells |
| (NAbs) | neutralizing antibodies |
| (CRs) | complete responses |
| (iE) | Induced encephalitis |
| (BCMA) | B-cell maturation antigen |
| (PFS) | progression-free survival |
| (TRAEs) | treatment-related adverse events |
| (mCRC) | colorectal cancer |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.